2020
DOI: 10.1016/s2213-8587(20)30113-3
|View full text |Cite
|
Sign up to set email alerts
|

Central nervous pathways of insulin action in the control of metabolism and food intake

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
146
0
9

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 148 publications
(162 citation statements)
references
References 123 publications
1
146
0
9
Order By: Relevance
“…These mechanisms are supported by balanced adjustments in insulin secretion to keep the metabolic system under tight control. The changes in insulin secretion and action are highly coordinated by the central nervous system (CNS) to ensure appropriate substrate switching between tissues to meet metabolic needs, such as in the postabsorptive to postprandial transition [2][3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…These mechanisms are supported by balanced adjustments in insulin secretion to keep the metabolic system under tight control. The changes in insulin secretion and action are highly coordinated by the central nervous system (CNS) to ensure appropriate substrate switching between tissues to meet metabolic needs, such as in the postabsorptive to postprandial transition [2][3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…Dopamine might mediate the central and peripheral insulin sensitivities, which indicate the relationship between NDs and glucose metabolism. 4 Furthermore, some kinds of diabetes drugs have been reported to have important impacts on the pathogenesis of these two major kinds of NDs.…”
Section: Introductionmentioning
confidence: 99%
“…Dopamine might mediate the central and peripheral insulin sensitivities, which indicate the relationship between NDs and glucose metabolism. 4 Furthermore, some kinds of diabetes drugs have been reported to have important impacts on the pathogenesis of these two major kinds of NDs. As a top-tier drug for the treatment of type 2 diabetes mellitus (T2DM), the role of metformin in dementia and PD is highly inconsistent, both in animal models and in clinical studies.…”
mentioning
confidence: 99%
“…Furthermore, in a crosssectional experiment, good hypothalamic insulin responsiveness was associated with lesser visceral fat mass, while no correlation was detected with subcutaneous fat mass. However, origins and mechanisms of brain insulin resistance remain elusive [2].…”
mentioning
confidence: 99%